Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Warren Buffett’s prostate cancer choices aren’t right for every man

Kevin Pho, MD
KevinMD
May 13, 2012
108 Shares
Share
Tweet
Share

A version of this column was published on April 24, 2012 in USA Today.

There has been a recent uptick of elderly men in my primary care clinic asking about prostate cancer, perhaps because they heard of Warren Buffett’s recent prostate cancer diagnosis and his proposed treatment.

Patients are wondering if they should also be screened. Other patients who already have been diagnosed are wondering if they should receive radiation treatment for their prostate cancer, as Buffett is planning to do. It is very important to remember that what’s right for Buffett may not be right for everyone else.

According to Buffett’s letter to shareholders, his prostate-specific antigen (PSA) had been “regularly checked for many years.” A sudden jump in his PSA level led to a prostate biopsy and cancer diagnosis. But should an 81-year-old man even be screened for prostate cancer?

The evidence says no. The U.S. Preventive Services Task Force, an independent panel of non-government clinicians providing data-based practice guidelines, recommends against prostate cancer screening for healthy men. Studies over the years, which have included participation of more than 300,000 men of various ages, have failed to show prostate cancer screening saves lives.

“If there is significant benefit, it should have been apparent by now, and it is not,” said Virginia Moyer, chair of the task force.

The guidelines of other organizations, which are not as stringent as those suggested by the task force, also question Buffett’s routine prostate cancer screening. For instance, the American Cancer Society and American Urological Association both recommend that doctors discuss the pros and cons of prostate cancer screening with men whose additional life expectancy exceeds 10 years. Even by that measure, screening Buffett — who can expect to live another eight years, based on actuarial data from the Social Security Administration — is questionable.

According to his letter, Buffett was diagnosed with Stage 1 prostate cancer, meaning the cancer had not spread beyond the prostate. The prognosis is generally excellent for this early-stage cancer, and for many men, just monitoring the cancer to ensure it doesn’t spread is proper. More aggressive treatments are available, including surgery and radiation therapy, which Buffett plans to undergo. The problem with these options is that the treatment may be worse than the disease.

The fact is, 75% of men over the age of 80 have cancer cells in their prostate, but in elderly men cancer grows so slowly that the men are much more likely to die of something else.

Moreover, for all men, prostate tests are not sophisticated enough to determine which of these cancers are dangerous and which are not. Without knowing, most men opt for treatment. But for every 1,000 men treated for prostate cancer, five will die of complications from surgery. Side effects of both SURGERY and radiation can include impotence, incontinence and frequent urination — all for a disease that, at Stage 1, has less than a 1% chance of causing death in the next 10 years.

The annual cost of PSA testing contributes $3 billion annually to health care spending, much of it paid for by Medicare and the Veterans Administration, without significant health benefits.  In fact, Richard J. Ablin, the scientist who discovered PSA, calls its widespread use a “public health disaster.”  Buffett’s high profile cancer coverage should have been an opportunity to educate the country that, for many, more conservative options would not only save them from harmful, unnecessary treatments, but also potentially reduce health costs.

Instead, some may view Buffett’s decision to screen for prostate cancer and aggressively treat it as the right thing to do. I’m not second-guessing the approach taken by Buffett and his medical team. And I also understand that some men would rather know their prostate cancer status and accept the risks of too much testing. but we should realize that Buffett’s prostate cancer path isn’t necessarily the right road for every man.

Kevin Pho is co-author of Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices. He is founder and editor of KevinMD.com, also on Facebook, Twitter, Google+, and LinkedIn.

Prev

I am just a medical student, I am not a doctor yet

May 13, 2012 Kevin 12
…
Next

Health care journalists have tendencies similar to those of doctors

May 13, 2012 Kevin 4
…

Tagged as: Mainstream media, Oncology/Hematology

Post navigation

< Previous Post
I am just a medical student, I am not a doctor yet
Next Post >
Health care journalists have tendencies similar to those of doctors

More by Kevin Pho, MD

  • Tragedy strikes Monday Night Football as Buffalo Bills safety Damar Hamlin suffers cardiac arrest. Is commotio cordis to blame?

    Kevin Pho, MD
  • Life as an MD online with Kevin Pho, MD

    Kevin Pho, MD
  • Essential clinician commentary on COVID-19 coronavirus from the KevinMD community

    Kevin Pho, MD

More in KevinMD

  • Tragedy strikes Monday Night Football as Buffalo Bills safety Damar Hamlin suffers cardiac arrest. Is commotio cordis to blame?

    Kevin Pho, MD
  • Life as an MD online with Kevin Pho, MD

    Kevin Pho, MD
  • KevinMD’s top posts of 2019

    Kevin Pho, MD
  • Let Physician Speaking by KevinMD highlight your event

    Kevin Pho, MD
  • Neurosurgeon keynote speaker joins Physician Speaking by KevinMD

    Kevin Pho, MD
  • Drs. Lynette Charity and C. Nicole Swiner highlight the Indiana State Medical Association’s 2019 Annual Convention

    Kevin Pho, MD
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The endless waves of chronic illness

      Michele Luckenbaugh | Conditions
    • Skydiving and surgery: How one doctor translates high-stress training to saving lives

      Alexandra Kharazi, MD | Physician
    • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

      Julie Craig, MD | Meds
    • How this doctor found her passion in ballroom dancing [PODCAST]

      The Podcast by KevinMD | Podcast
    • Surviving and thriving after life’s most difficult moments

      Rebecca Fogg, MBA | Conditions
    • Don’t be caught off guard: Read your malpractice policy today

      Aaron Morgenstein, MD & Laura Fortner, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosis
  • CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer
  • Fla. Doc Charged With Murder; McConnell Exits Rehab Facility; BPA on Store Receipts
  • FDA Faults Next-Gen Olympus Duodenoscopes
  • CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer

Meeting Coverage

  • CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer
  • CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer
  • Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis
  • Biomarkers of Response With Enfortumab Vedotin in Advanced Urothelial Cancer
  • At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The endless waves of chronic illness

      Michele Luckenbaugh | Conditions
    • Skydiving and surgery: How one doctor translates high-stress training to saving lives

      Alexandra Kharazi, MD | Physician
    • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

      Julie Craig, MD | Meds
    • How this doctor found her passion in ballroom dancing [PODCAST]

      The Podcast by KevinMD | Podcast
    • Surviving and thriving after life’s most difficult moments

      Rebecca Fogg, MBA | Conditions
    • Don’t be caught off guard: Read your malpractice policy today

      Aaron Morgenstein, MD & Laura Fortner, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Warren Buffett’s prostate cancer choices aren’t right for every man
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...